Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Identification of candidate serum proteins for classifying well-differentiated small intestinal neuroendocrine tumors.

Darmanis S, Cui T, Drobin K, Li SC, Öberg K, Nilsson P, Schwenk JM, Giandomenico V.

PLoS One. 2013 Nov 25;8(11):e81712. doi: 10.1371/journal.pone.0081712. eCollection 2013.

2.

Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.

Cui T, Hurtig M, Elgue G, Li SC, Veronesi G, Essaghir A, Demoulin JB, Pelosi G, Alimohammadi M, Öberg K, Giandomenico V.

PLoS One. 2010 Dec 30;5(12):e16010. doi: 10.1371/journal.pone.0016010.

3.

Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.

Norlén O, Stålberg P, Öberg K, Eriksson J, Hedberg J, Hessman O, Janson ET, Hellman P, Åkerström G.

World J Surg. 2012 Jun;36(6):1419-31. doi: 10.1007/s00268-011-1296-z.

PMID:
21984144
4.

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.

Francis JM, Kiezun A, Ramos AH, Serra S, Pedamallu CS, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis A, Manzo V, Contractor T, Philips J, Nickerson E, Pho N, Hooshmand SM, Brais LK, Lawrence MS, Pugh T, McKenna A, Sivachenko A, Cibulskis K, Carter SL, Ojesina AI, Freeman S, Jones RT, Voet D, Saksena G, Auclair D, Onofrio R, Shefler E, Sougnez C, Grimsby J, Green L, Lennon N, Meyer T, Caplin M, Chung DC, Beutler AS, Ogino S, Thirlwell C, Shivdasani R, Asa SL, Harris CR, Getz G, Kulke M, Meyerson M.

Nat Genet. 2013 Dec;45(12):1483-6. doi: 10.1038/ng.2821. Epub 2013 Nov 3.

5.

The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.

Wang YC, Zuraek MB, Kosaka Y, Ota Y, German MS, Deneris ES, Bergsland EK, Donner DB, Warren RS, Nakakura EK.

Endocr Relat Cancer. 2010 Feb 18;17(1):283-91. doi: 10.1677/ERC-09-0243. Print 2010 Mar.

6.

[Gastroenteropancreatic neuroendocrine/endocrine tumors. Current pathologic-diagnostic view].

Schmitt-Gräff A, Nitschke R, Wiedenmann B.

Pathologe. 2001 Mar;22(2):105-13. Review. German.

PMID:
11321726
7.

Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.

Modlin IM, Gustafsson BI, Drozdov I, Nadler B, Pfragner R, Kidd M.

Ann Surg Oncol. 2009 Feb;16(2):487-98. doi: 10.1245/s10434-008-0251-1. Epub 2008 Dec 3.

PMID:
19050963
8.

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.

Hashemi J, Fotouhi O, Sulaiman L, Kjellman M, Höög A, Zedenius J, Larsson C.

BMC Cancer. 2013 Oct 29;13:505. doi: 10.1186/1471-2407-13-505.

9.

Pathology - grading and staging of GEP-NETs.

Capelli P, Fassan M, Scarpa A.

Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):705-17. doi: 10.1016/j.bpg.2013.01.003. Review.

PMID:
23582914
10.

The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.

Li SC, Martijn C, Cui T, Essaghir A, Luque RM, Demoulin JB, Castaño JP, Öberg K, Giandomenico V.

PLoS One. 2012;7(10):e48411. doi: 10.1371/journal.pone.0048411. Epub 2012 Oct 31.

11.

Classification of neuroendocrine tumors.

Klöppel G.

Verh Dtsch Ges Pathol. 1997;81:111-7. Review.

PMID:
9474861
12.

A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.

Modlin IM, Gustafsson BI, Pavel M, Svejda B, Lawrence B, Kidd M.

Neuroendocrinology. 2010;92(3):143-57. doi: 10.1159/000319784. Epub 2010 Aug 23.

13.

[Neuroendocrine tumors of the small bowels are on the rise: early tumors and their management].

Scherübl H, Schwertner C, Steinberg J, Stölzel U, Pohl J, Dralle H, Klöppel G.

Z Gastroenterol. 2010 Mar;48(3):406-13. doi: 10.1055/s-0028-1109862. Epub 2010 Feb 24. Review. German.

PMID:
20183784
14.

Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.

Tang LH, Gonen M, Hedvat C, Modlin IM, Klimstra DS.

Am J Surg Pathol. 2012 Dec;36(12):1761-70. doi: 10.1097/PAS.0b013e318263207c.

PMID:
23026928
15.

Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.

Li SC, Essaghir A, Martijn C, Lloyd RV, Demoulin JB, Oberg K, Giandomenico V.

Mod Pathol. 2013 May;26(5):685-96. doi: 10.1038/modpathol.2012.216. Epub 2013 Jan 18.

16.

Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.

Drozdov I, Kidd M, Nadler B, Camp RL, Mane SM, Hauso O, Gustafsson BI, Modlin IM.

Cancer. 2009 Apr 15;115(8):1638-50. doi: 10.1002/cncr.24180.

17.

Small intestinal neuroendocrine cell pathobiology: 'carcinoid' tumors.

Kidd M, Modlin IM.

Curr Opin Oncol. 2011 Jan;23(1):45-52. doi: 10.1097/CCO.0b013e328340d006. Review.

PMID:
21045686
18.

Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy.

Bellutti M, Fry LC, Schmitt J, Seemann M, Klose S, Malfertheiner P, Mönkemüller K.

Dig Dis Sci. 2009 May;54(5):1050-8. doi: 10.1007/s10620-008-0456-y. Epub 2008 Sep 4.

PMID:
18770038
19.

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.

Boudreaux JP, Klimstra DS, Hassan MM, Woltering EA, Jensen RT, Goldsmith SJ, Nutting C, Bushnell DL, Caplin ME, Yao JC; North American Neuroendocrine Tumor Society (NANETS).

Pancreas. 2010 Aug;39(6):753-66. doi: 10.1097/MPA.0b013e3181ebb2a5.

PMID:
20664473
20.

[Indications and operative procedures for neuroendocrine liver metastases].

Musholt TJ, Lang H.

Chirurg. 2009 Feb;80(2):113-21. doi: 10.1007/s00104-008-1614-7. Review. German.

PMID:
19212693
Items per page

Supplemental Content

Write to the Help Desk